Inadequate Detection of the FSHR Complicates Future Research on Extragonadal FSHR Localization
Overview
Authors
Affiliations
Introduction: Recently, follicle stimulating hormone (FSH) through interaction with its receptor (FSHR) has been proposed to play a role in postmenopausal osteoporosis and cardiovascular disease, rather than the loss of estrogen. To explore this hypothesis, unravelling which cells express extragonadal FSHR on protein level is key.
Methods: We used two commercial anti-FSHR antibodies and validated them by performing immunohistochemistry on positive (ovary, testis) and negative controls (skin).
Results: The monoclonal anti-FSHR antibody could not identify the FSHR in ovary or testis. The polyclonal anti-FSHR antibody stained the granulosa cells (ovary) and Sertoli cells (testis), yet there was equally intense staining of other cells/extracellular matrix. Furthermore, the polyclonal anti-FSHR antibody also stained skin tissue extensively, suggesting that the antibody stains more than just FSHR.
Discussion: The findings in this study may add accuracy to literature on extragonadal FSHR localization and warrants attention to the use of inadequate anti-FSHR antibodies to value the potential role of FSH/FSHR in postmenopausal disease.
Atlas of Fshr expression from novel reporter mice.
Chen H, Fang H, Liu J, Chang S, Cheng L, Sun M Elife. 2025; 13.
PMID: 39773308 PMC: 11709436. DOI: 10.7554/eLife.93413.
Palak E, Ponikwicka-Tyszko D, Pulawska-Moon K, Sztachelska M, Milewska G, Modzelewska B Mol Med. 2024; 30(1):241.
PMID: 39633277 PMC: 11619181. DOI: 10.1186/s10020-024-01015-2.
Libby A, Solt C, Jackman M, Sherk V, Foright R, Johnson G Am J Physiol Endocrinol Metab. 2024; 326(5):E626-E639.
PMID: 38536037 PMC: 11208003. DOI: 10.1152/ajpendo.00400.2023.